Summary
It contains active binding interference factor components, specifically targeting at endogenous interference in HAMA, RF, HA and other samples in immune detection. This blocker especially improves the ability of anti-heterophilic antibody (HA). Applicable to all immunoassay platforms LF, CLIA, EIA, TIA, etc. Purity greater than 90%, concentration of 10mg/ml (0.01M PBS, pH7.4), 0.2μm filtration, no preservatives added.
Active blockers Blockers are specifically targeted at the interference of heterophil antibodies and rheumatoid factors in immune detection. They are suitable for immune detection system and can effectively eliminate immune interference, improve the reliability of detection, and reduce the incidence of false positive and false negative.
Features：
1. The concentration range of the blocker should be 30µg-300µg/ml. The final working concentration should be determined by gradient experiment, which is recommended for the first time.
The use of concentration from a higher concentration, to determine the effect of the gradient dilution to a lower concentration, choose a more appropriate economic with concentration.
2. Immunolateral chromatography reagents are recommended to be added to the marker pad or sample pad treatment solution; chemiluminescent reagent or enzyme linked immunoassay.
The agent is recommended to be added to the magnetic bead solution or the enzyme label solution, or to the sample solution; immunoturbidimetric products are recommended to be added to R1 for work In the liquid.
3. It is suggested to select a variety of blockers for testing, and find a suitable single blocker product or combination of blockers for use.
Purity: ≥90%
Specifications
50 mg, 100 mg, 250 mg, 500 mg, 1000 mg, 5000 mg
Storage and Expiry Date
Store at - 20℃ . The product is valid for 36 months.
bio-equip.cn
中文
